Theme: Innovative findings and Novel technologies in Clinical Nephrology

Clinical Nephrology 2017

Clinical Nephrology 2017

Conference Series LLC invites all the participants from all over the world to attend 12th Annual conference on Clinical Nephrology JULY 10-12,2017  Kuala Lumpur, Malaysia during  which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

ClinicalNephrology 2017  is a global platform to discuss and learn about Clinical Nephrology,Chronic Kidney Diseases, Dialysis and recent Renal therapies, Nephrology and hypertension, Nephrotic Syndrome and renal failure, Hereditary Kidney Disorders, Diabetic Nephrology, Nephrology- Diagnosis, Treatment, Prognosis, Drugs For Kidney Diseases, Diet, Lifestyle Changes.

Track 1: Clinical Nephrology:

The kidneys are vital for life with their complex network of blood vessels and intricate network of tubes and tubules that filter blood of its waste products and excess water.The kidneys maintain the fluid, electrolyte, and acid-base regulation that are altered by several disease conditions as well as drugs and toxins. Nephrology (from Greek νεφρός nephros "kidney", combined with the suffix -logy, "the study of") is a specialty of medicine and pediatrics that concerns itself with the study of normal kidneyfunction , kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Nephrology deals with study of the normal working of the kidneys as well as its diseases. The diseases that come under the scope of nephrology include:-

Glomerular disorders that affect the tiny filtering systems of the kidneys called the glomerulus, Urine abnormalities such as excess excretion of protein, sugar, blood, casts, crystals etc.Tubulointerstitial diseases affecting the tubules in the kidneys, Renal vascular diseases affecting the blood vessel networks within the kidneys, Kidney failure that can be sudden or acute or long term or chronic, Kidney and bladder stones, Kidney infections, Cancers of the kidneys, bladder, and urethra, Effects of diseases like diabetes and high blood pressure on kidneys, Acid base imbalances, Nephroticsyndrome  and nephritis, Ill effects of drugs and toxins on the kidneys, Dialysis and its long term complications - dialysis includes hemodialysis as well as peritoneal dialysis, Autoimmune diseases including autoimmune vasculitis, lupus, etc. Polycystic kidneys diseases where large cysts or fluid filled sacs are formed within the kidney impairing its functions - this is a congenital and inherited or genetic condition.

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 2: Chronic Kidney Diseases

 Chronic Kidney Diseases includes conditions that damage your kidneys and decrease their ability to keep you healthy by doing the jobs listed. If kidney disease gets worse, wastes can build to high levels in your blood and make you feel sick. You may develop complications like high blood pressure, anemia (low blood count), weak bones, poor nutritional health and nerve damage. Also, kidney disease increases your risk of having heart and blood vessel disease. These problems may happen slowly over a long period of time. Chronic Kidney Diseases may be caused by diabetes, high blood pressure and other disorders. Early detection and treatment can often keep chronic kidney disease from getting worse. When kidney Diseases  progresses, it may eventually lead to kidney failure, which requires dialysis or a kidney transplant to maintain life. The two main causes of chronic kidney disease are diabetes and high blood pressure, which are responsible for up to two-thirds of the cases. Diabetes happens when your blood sugar is too high, causing damage to many organs in your body, including the kidneys and heart, as well as blood vessels, nerves and eyes. High blood pressure, or hypertension, occurs when the pressure of your blood against the walls of your blood vessels increases.

Related conferences: : 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 3: Nephrology and Hypertension

Patients with all types of kidney disease and hypertension. This includes kidney stones, chronic or acute kidney diseases due to any cause, resistant or secondary hypertension, unexplained proteinuria or hematuria, cystic kidney diseases, inherited kidney diseases, fluid and electrolyte homeostasis abnormalities, pregnancy pregnancy related Kidney Diseases, vascular kidney diseases, nephrotic syndrome, glomerulonephritis, and others.High blood pressure (also called hypertension) occurs when the force of your blood against your artery walls increases enough to cause damage. For people who have diabetes or chronic kidney disease, blood pressure of 130/80 or more is considered high. Have a family history of high blood pressure. your chances of developing high blood pressure may be increased if you: Have Chronic kidney disease (CKD), Are overweight. Are African American. Use a lot of table salt, eat a lot of packaged or fast foods,Use birth control pills, Have diabetes,Use illegal drugs, Drink large amounts of alcohol (beer, wine, or liquor). Some types of kidney failure may cause high blood pressure. More often it is high blood pressure that causes kidney Diseases .

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 4: Nephrotic Syndrome and Renal Failure

Nephroticsyndrome is kidney disease with proteinuria, hypoalbuminemia, and edema. Nephrotic-range proteinuria is 3 grams per day or more. On a single spot urine collection, it is 2g of protein per gram of urine creatinine. There are many specific causes of nephrotic syndrome. These include Kidney diseases such as minimal-change nephropathy (Analgesic Nephropathy), focal glomerulosclerosis, and membranous nephropathy. Nephrotic syndrome can also result from systemic diseases that affect other organs in addition to the kidneys, such as diabetes, amyloidosis, and lupus erythematosus. Nephrotic syndrome may affect adults and children, of both sexes and of any race. It may occur in typical form, or in association with nephritic syndrome. The latter connotes glomerular inflammation, with hematuria and impaired kidney function. Nephrotic syndrome can be primary, being a disease specific to the kidneys, or it can be secondary, being a renal manifestation of a systemic general illness. In all cases, injury to glomeruli is an essential feature.

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 5: Diabetic Nephrology

Diabetic Diabetic Nephropathy (DN) is typically defined by macro albuminuria—that is, a urinary albumin excretion of more than 300 mg in a 24-hour collection—or macro albuminuria and abnormal renal function (Renal function test) as represented by an abnormality in serum creatinine, calculated creatinine clearance, or glomerular filteration  rate (GFR). Clinically, diabetic nephropathy is characterized by a progressive increase in proteinuria and decline in GFR, hypertension, and a high risk of cardiovascular morbidity and mortality. Diabetic nephropathy is a clinical syndrome characterized by the following: Persistent albuminuria (>300 mg/d or >200 μg/min) that is confirmed on at least 2 occasions 3-6 months apart ,Progressive decline in the glomerular filtration rate (GFR), Elevated arterial blood pressure. Proteinuria was first recognized in diabetes mellitus in the late 18th century. In the 1930s, Kimmelstiel and Wilson described the classic lesions of nodular glomerulosclerosis in diabetes associated with proteinuria and hypertension. By the 1950s, kidney Disease  was clearly recognized as a common complication of diabetes, with as many as 50% of patients with diabetes of more than 20 years having this complication Currently, diabetic nephropathy is the leading cause of chronic kidney disease in the United States and other Western societies. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes. Diabetes is responsible for 30-40% of all end end stage renal disease (ESRD) cases in the United States. Generally, diabetic nephropathy is considered after a routine urinalysis and screening for micro albuminuria in the setting of diabetes.

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 6: Hereditary Kidney Disorders

Renal cystic disease comprises a wide range of disease entities. They can be classified as either (1) hereditary or acquired or (2) systemic or renal confined diseases that have the common feature of multiple renal cysts. Each disease entity differs in its presentation, prognosis, and management. Renal cysts  are smooth-walled, fluid-filled circular structures formed by focal outpouching of renal tubules. The pathogenesis of cyst formation has not been entirely elucidated. However, tremendous strides have been made in recent years. For autosomal dominant and autosomal recessive polycystic polycystic kidney Diseases (ADPKD and ARPKD), a picture is starting to emerge. Defects in the primary ciliary sensing mechanisms, intracellular calcium regulation, and cellular cyclic AMP (cAMP) accumulation all seem to play a role in the altered cellular phenotype and functions.

Today, treatment includes risk modification, management of complications, and Acute Renal replacement Therapy or dialysis. There is no definitive therapy to eliminate or to retard cyst growth. A better understanding of its pathogenesis offers hope in the near future for correcting the underlying abnormalities in cystic pathways. Advances in genetic techniques are providing novel insights into kidney diseases (Hereditary Diseases), especially diagnosis, classification, pathogenesis and therapy.

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 7: Dialysis and recent renal therapies

Dialysis is the artificial process of eliminating waste (diffusion) and unwanted water (ultrafiltration) from the blood. Our kidneys do this naturally. Some people, however, may have failed or damaged kidneys which cannot carry out the function properly - they may need dialysis. In other words, dialysis is the artificial replacement for lost kidney function (Acute renal replacement therapy).Dialysis may be used for patients who have become ill and have acute kidney failure (temporary loss of kidney function), or for fairly stable patients who have permanently lost kidney function  When we are healthy our kidneys regulate our body levels of water and minerals, and remove waste. The kidneys also produce erythropoietin and 1,25-dihydroxycholecalciferol (calcitriol) as part of the endocrine system. Dialysis does not correct the endocrine functions of failed kidneys - it only replaces some kidney functions, such as waste removal and fluid removal . Dialysis and altitude - A study published in February 2009 found that death rates for dialysis patients are 10%-15% lower for those whose homes are higher than 4,000 feet, compared to those who live at sea level. Some countries, such as the UK, are predicting a doubling of the number of patients on dialysis machine. Approximately 1,500 liters of blood are filtered by a healthy person's kidneys each day. We could not live if waste products were not removed from our kidneys. People whose kidneys either do not work properly or not at all experience a buildup of waste in their blood. Without dialysis the amount of waste products in the blood would increase and eventually reach levels that would cause coma and death. Ambulatory Peritoneal Dialysis is also used to rapidly remove toxins or drugs from the blood.

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 8: Nephrology- Diagnosis, Treatment, Prognosis

The kidneys are bean-shaped organs located on either side of the lower back. They are extremely important for the body in that they process waste and toxins before they are sent to the bladder as urine. If the kidney becomes damaged or fails completely, it becomes unable to properly process this waste. This lack of function causes Renal failure , also called Kidney failure. The kidneys play a vital role in maintaining every day bodily function. They not only filter the blood and get rid of waste, but they also balance out electrolyte levels in the body which help encourage the production of red blood cells and normalize blood pressure. Understanding what kidney failure is will help you better prevent it from occurring. Kidney failure, also known as renal failure, may not present many symptoms in the beginning. However, as the kidneys continue to decrease in function, they become unable to regulate water and electrolyte balances, clear waste products from the body, and promote red blood cell production which leads to the onset of symptoms including: lethargy, weakness, shortness of breath and occasional swelling. If left untreated, then life-threatening symptoms can occur, which range from heart failure to coma.

When kidney function gets significantly reduced due to kidney failure, the damage cannot usually be reversed. However, if the proper steps are taken early enough, then it could slow down the progress of kidney failure or even halt it altogether. The treatment for kidney failure differs depending on what phase the kidney failure is and other individual factors. For those whose kidneys no longer function well enough on their own without renal therapy, specialist will typically recommend either renal dialysis or a kidney transplant. There are two kinds of dialysis—Hemodialysis and Peritonel Dialysis ( Ambulatory Peritoneal Dialysis). Dialysis does some of the things a normal kidney does, such as: removes extra water from the body and removes the waste products that have built up in the blood. Hemodialysis is usually done in a dialysis center, however there are some patients who use this therapy at home. Nurses and technicians do your dialysis treatment.

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 9: Drugs For Kidney Diseases

Depending on the underlying cause, some types of kidney disease can be treated. Often, though, chronic kidney disease has no cure. In general, treatment consists of measures to help control signs and symptoms, reduce complications, and slow progression of the disease. If your kidneys become severely damaged, you may need treatment for end-stage kidney Diseases . There are four types of medicine that can help people with CKD: Angiotensin-converting enzyme inhibitors (ACEIs), Angiotensin II receptor blockers/antagonists (ARBs),Beta-blockers, Statins. ACEIs, ARBs, and beta blockers-blockers are all types of medicine used to lower blood pressure, but they work in different ways. ACEIs and ARBs may slow kidney damage even in people who do not have high blood pressure. Statins are a type of medicine used to lower cholesterol. Although medicine cannot reverse chronic kidney disease, it is often used to help treat symptoms and complications and to slow further kidney damage. Most people who have chronic kidney disease have problems with high blood pressure at some time during their disease. Medicines that lower blood pressure help to keep it in a target range and stop any more kidney damage. Common blood pressure medicines include: ACE inhibitors, Angiotensin II receptor blockers (ARBs), Beta-blockers, Calcium channel blockers. Medicines may be used to treat symptoms and complications of chronic kidney disease.

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

Track 10: Diet, Lifestyle Changes

Following a healthy lifestyle is good for people with kidney disease, especially if you have diabetes, high blood pressure, or both. Talk with your dietitian, diabetes educator  or other health care professional about which actions are most important for you to take. As you will see, many of these actions are related. Keep your blood pressure at the target set by your health care provider. For most people, the blood pressure target is less than 140/90 mm Hg. Aim for less than 2,300 milligrams (mg) of sodium each day. If you have diabetes, control your blood glucose level. Good blood glucose  control may help prevent or delay diabetes complications, including kidney disease. Keep your blood cholesterol in your target range. Diet being active, maintaining a healthy weight, and medicines can all help control your blood cholesterol level. Maintain Diet and obesity.Take medicines the way your provider tells you to. What you eat and drink may help slow down kidney Diseases. Some foods may be better for your kidneys than others. Most of the salt and sodium additives people eat come from prepared foods, not from the salt shaker. Cooking your food from scratch gives you control over what you eat. Your provider may suggest you see a dietitian. A dietitian can teach you how to choose foods that are easier on your kidneys about sodium, protein, phosphorus, potassium, and how to read food labels. The steps below will help you eat right as you manage your kidney disease. Cigarette smoking can make kidney damage worse.

Related Conferences: 7th European Nephrology Conference October 24-25, Rome, Italy; 6th International Conference on Nephrology&therapeutics, September 29-30, 2016, Orlando, USA; International Conference on Kidney Transplantation, September 29-30, 2016, Orlando, USA; 5th Global Nephrologists Annual Meeting, March 31-April 02, 2016 ,Valencia, Spain; 14th Mayo Clinic Annual Update in Nephrology and Kidney Transplantation 2015, September 18 -19, 2015, Minneapolis , United States; 46th Annual Conference of Indian Society of Nephrology 2015, December 17- 20, 2015; Bengaluru, India, 21st International Conference on Advances in Critical care Nephrology , February 16-19, 2016, San Diego, USA; 2nd Azerbaijan-Turkey Nephrology Congress, Oct 09-10, 2015, Baku, Azerbaijan.

With the unique feedback and generous response received for the former event, Conference Series LLC proudly announces the commencement of 12th Annual conference on Clinical Nephrology’ during July 10-12, 2017 Kuala Lumpur, Malaysia.This include prompt keynote presentation, oral talks, poster presentations, and Exhibitions. It lays a well-built platform for researches in Acute and chronic renal diseases caused by diabetes mellitus, stone disease, hypertension, poisons, infections and hereditary illness, diagnosis and management. This Conference also focuses upon the latest therapeutic advancements in treating the renal diseases such as Hemofiltration, Dialysis, Diabetic Nephropathy and Renal Replacement Therapy, Renal Transplantation, etc. Clinical Nephrology conference targets on Nephrologists, Doctors, and people from academia, Research Scholars, Industrialists, Business delegates, Students and eminent speakers, Delegates.

Clinical Nephrology has been fostering the need to control the impact of permanent renal disease within the public health environment .The lack of a systematized control provided through a measurable program has greatly impacted on the level of hospital expense since they have increased their case-mix risk, family economies deteriorate and health care pays for a higher morbimortality that could be avoided with better surveillance and epidemiological control. Through this conference we pave the way to overcome the kidney diseases. The Theme of  the Conference is to "Innovative findings and Novel technologies in Clinical Nephrology". The importance of Clinical Nephrology Conference is to  get the knowledge and recent developments in Clinical Nephrology to everyone and get awareness in Nephrology.

Why to attend?

  • Exchange ideas and knowledge of treating kidney diseases and indicate innovations in diagnosis and advances in clinical practice in the field of nephrology across continents, institutions, and individuals.
  • Outline the novel therapeutic approaches in the field of nephrology
  • Conduct presentations, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event.
  • World-renowned speakers, the most recent techniques, developments, and the newest updates in Nephrology is hallmark of this conference.

Target Audience:

·         Nephrology Scientists

·         Nephrology Researchers

·        Nephrology Nurses

·        Nephrology Associations and Societies

·         Nephrology Faculty

·         Medical Colleges

·         Nephrology Physicians

·         Training Institutes

·         Business Entrepreneurs

·         Manufacturing Medical Devices Companies

About the Conference:

12th Annual conference on Clinical Nephrology will be hosted at Baltimore, USA during July 10-12, 2017 with the innovative theme "Innovative findings and Novel technologies in Clinical Nephrology”. This conference mainly focuses on spreading the awareness about challenges in this field and how to prevent the Kidney diseases. We are awaiting a great scientific faculty from USA as well as other continents and expect a highly interesting scientific as well as a representative event.

Importance & Scope:

Clinical Nephrology has been fostering the need to control the impact of permanent renal disease within the public health environment .The lack of a systematized control provided through a measurable program has greatly impacted on the level of hospital expense since they have increased their case-mix risk, family economies deteriorate and health care pays for a higher morbimortality that could be avoided with better surveillance and epidemiological control. However, nephrology associations have paved the way in this effort.

The role of the kidney transplant  Social Worker is to assist patients and families reduce stress and achieve optimum functioning in the psychological, emotional and social areas of their lives.They draw on their knowledge of community resources in order to assist with issues such as accommodation, transport and finances. All members offer support, counselling and education relating to their speciality and inevitably some role overlap occurs. It is vital that the channels of communication are established so information gained which is relevant to another disciplines is shared. It is important to be sensitive to the fact that any contact may be cutting across another's treatment plan for that person. Social work supports the donor and family.

Why Malaysia?

The Malaysia is now the most popular country it is a one of developed country and has the world's largest economy by nominal and real GDP, benefiting from an abundance of natural resources and high worker productivity.While the Malaysia economy is considered post-industrial, the country continues to be one of the world's largest manufacturers as well as leader in scientific research and technological innovations.Malaysia is having 15-20 International associations related to Nephrology so scope is more. The United States has one of the world’s finest university systems, with outstanding programs in virtually all fields.

The United States is home to several thousand colleges and universities, Famous hospitals, Research Institutes, associations and organizations boasting at least ten times as many campuses as in any other country.American universities include many prestigious institutions that are respected globally and other side USA having worldwide famous places to see.USA having best places to stay it is a city full of American icons. The great American experience is about so many things.

Associations & Society Associated with Clinical Nephrology in Malaysia:

·American Society of Nephrology

·Renal Association

·International Society of Nephrology (ISN) Gateway

·ClinMed International Library

·International Federation of Kidney Foundations

·American Kidney Fund (AKF)

·American Society of Transplantation (AST)

·American Society of Diagnostic & Interventional Nephrology (ASDIN)

·Board of Nephrology Examiners, Inc. Nursing and Technology (BONENT)

· California Dialysis Council (CDC)

·International Society for Peritoneal Dialysis (ISPD)

·International Society for Hemodialysis (ISHD)

· International Society for Nephrology Technicians and Technologists (ISNTT)

·National Kidney Foundation (NKF)

Associations & Society Associated with Clinical Nephrology Worldwide:

  • Australian and New Zealand Society of Nephrology
  • Australian Kidney Foundation
  • Canadian Association of Nephrology Nurses and Technologists
  • German Kidney Foundation
  • European Renal Association
  • Italian Society of Nephrology
  • Japanese Society for Dialysis Therapy
  • Australian and New Zealand Society of Nephrology
  • International Society of Nephrology
  • Kidney & Urology Foundation of America
  •   National Foundation for Transplants
  • National Kidney Foundation Singapore
  • North West Dialysis Service (NWDS)
  • Transplantation Society of Australia and New Zealand
  •  World Kidney Fund

Universities Associated with Clinical Nephrology Malaysia:

  • Stanford University
  • Vanderbilt University
  • University of Pennsylvania
  • Yale University
  • Duke University
  • University of California
  • University of Illinois
  • John Hopkins University
  • University of Maryland
  • University of Florida
  • University of Alabama
  • University of Michigan
  • University of Winconsin
  • Northwestern University
  • Ohio University

Universities Associated with Clinical Nephrology Worldwide:

  • University of Calgary
  • California NorthState University College of Medicine
  • Stanford University School of Medicine
  • Universita Cattolica del Sacro Cuore
  • La Sapienza University
  • Stanford University
  • Vanderbilt University
  • University of Pennsylvania
  • Yale University
  • Duke University
  • University of California
  • University of Illinois
  • John Hopkins University
  • University of Maryland
  • Ohio University

 

Hospitals Associated with Clinical Nephrology in Malaysia:

  • Boston children’s Hospital
  • Ottawa Hospital
  • Massachusetts General Hospital
  • Children's Hospital of Pittsburgh of UPMC
  • Texas Children's Hospital, Houston
  • University of Michigan C.S. Mott Children's Hospital, Ann Arbor
  • Nationwide Children's Hospital, Columbus, Ohio

Hospitals Associated with Clinical Nephrology Worldwide:

  • University of Iowa Children's Hospital
  • St. Louis Children's Hospital
  • Royal Children's Hospital, Parkville
  • Children's Hospital of Western Ontario
  • Alder Hey Children's Hospital - Liverpool
  • Centennial Hills Hospital
  • Leicester's Hospitals
  • Phoenix Children's Hospital Foundation
  • UC Davis Children's Hospital
  • Shriners Hospitals for Children
  • University of Iowa Children's Hospital

Industries Associated with Clinical Nephrology in Malaysia:

     ·Mehta - Clinical and Translational Research Institute (CTRI)

  • Spectrum Pharmaceuticals
  • PDL BioPharma
  • Sierra Sciences
  • GlaxoSmithKline
  • PharmaResearch

Industries Associated with Clinical Nephrology Worldwide:

  • Boehringer Ingelheim
  • Roche
  • Bristol-Myers Squibb
  • United Therapeutics
  • Astellas
  • Actelion
  • Merck & Co.
  • Takeda
  • Gilead Sciences
  • Johnson & Johnson

 

Estimated market growth of Clinical Nephrology:

The North American interventional Nephrology devices market is expected to reach $20.5Billion by 2018. Global Interventional Nephrology market is estimated to reach US$ 20.5 billion by 2018. Global Interventional Nephrology Devices Industry market is worth US$23.6 billion by 2016, growing CAGR 6.4% for the analysis period 2012-2018 respectively

Market value in Clinical Nephrology:

Products Manufactured by the industry related Clinical Nephrology Research and global nephrology market will grow from nearly $4.0 billion in 2012 to $5.5 billion in 2013. In 2014 to be worth $7.3 billion for a compound annual growth rate of 6.4%.This year, the global market for products used in the fight against kidney diseases will be worth an estimated $5.5 billion, according to a new technical market research report, the Global Nephrology Market, from Malaysia Research. Market revenue is forecast to increase at a five-year compound annual growth rate (CAGR) of 6.4% from 2013 to 2018, totally nearly $20.5 billion in 2018.

Allotment (in Million Dollars) to Clinical Nephrology Research:

These are the find allotted by NIH in various years to clinical Nephrology research department. The Kidney Foundation has over $500 million to 605 basic science, translational and clinical CHD research projects at leading research centers across the Malaysia and Canada. The maximum level of funding is $80,000 per year in Malaysia and shall be used principally to support the global development as well as training-related expenses. Referrals for those in need of a kidney transplant have more than doubled in the past two years due to these excellent results and the unique expertise of transplant surgeons and physicians.

Statistics of Physicians, Researchers and Academicians working on clinical Nephrology Research:

The main part of the world associated with Clinical Nephrology field are Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors, Students and Writers of Pediatric Nephrology Department as well as Founders and Employees of the related companies, Associations members, related organizations, laboratories members etc. 

See more at: http://clinicalnephrology.conferenceseries.com

 

 

Clinical Nephrology 2016

 In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects, 6th Annual conference on Clinical & Pediatric Nephrology” hosted by the  Conference Series LLC was held during May 9-10, 2016 at New Orleans, USA, with the themeExploring the new technologies in Clinical Nephrology and Renal Therapies”. Generous response and active participation received from the Researchers, Scientists , Principal Investigators and Editorial Board Members  of Conference Series LLC helped in making this meeting an ostentatious success. 

Clinical Nephrology 2016 Organizing Committee would like to thank the Moderator of the conference, Dr. Falguni Das, University of Texas Health Science Center at San Antonio who contributed a lot for the smooth functioning of this event.
 

The conference was initiated with a warm Welcome Note and the Book Launch by Honorable Guests and the Keynote Forum. The conference proceedings were carried out through various scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations: 

  • “Ocular disorders detected in end stage renal disease undergoing hemodialysis patients and laboratorial correlations” by Dario Xavier Jimenez Acosta, Central University of Ecuador, Ecuador
     
  • “Treatment of critically ill children with kidney injury by sustained low efficiency daily diafiltration”, by Ching-Yuang Lin, China Medical University, Taiwan

Our Organization extends its warm gratitude to all the Honorable Guests of  Clinical Nephrology 2016:

  • Dr. Darío Xavier Jiménez Acosta, Central University of Ecuador, Ecuador
  • Dr. Falguni Das, University of Texas Health Science Center, USA
  • Dr. Xiaorong Liu, Beijing Children’s Hospital, China
  • Dr. K S Nayak, Deccan Institute of Nephrology and Renal Transplantation, India

Conference Series LLC  is privileged to felicitate Clinical Nephrology 2016 Organizing Committee, Keynote Speakers, Chairs & Co-Chairs and also the Moderator of the conference whose support and efforts made the conference to move in the path of success. Conference Series LLC  thanks every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Clinical Nephrology 2016

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Clinical Nephrology 2016.

With the unique and affirmative feedbacks from the conference, We would like to announce the commencement of the 12th Annual Conference on Clinical Nephrology which will be hosted in July 20-21,2017 Baltimore.


Past Reports  Gallery  

Clinical Nephrology 2016

Pediatric Nephrology 2016

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects, 6th Annual conference on Clinical & Pediatric Nephrology” hosted by the  Conference Series LLC was held during May 9-10, 2016 at New Orleans, USA, with the theme “Exploring the new technologies in Clinical Nephrology and Renal Therapies”. Generous response and active participation received from the Researchers, Scientists , Principal Investigators and Editorial Board Members  of Conference Series LLC helped in making this meeting an ostentatious success.

Pediatric Nephrology  2016 Organizing Committee would like to thank the Moderator of the conference, Dr. Falguni Das, University of Texas Health Science Center at San Antonio who contributed a lot for the smooth functioning of this event.

The conference was initiated with a warm Welcome Note and the Book Launch by Honorable Guests and the Keynote Forum. The conference proceedings were carried out through various scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

    “Ocular disorders detected in end stage renal disease undergoing hemodialysis patients and laboratorial correlations” by Dario Xavier Jimenez Acosta, Central University of Ecuador, Ecuador

    “Treatment of critically ill children with kidney injury by sustained low efficiency daily diafiltration”, by Ching-Yuang Lin, China Medical University, Taiwan

Our Organization extends its warm gratitude to all the Honorable Guests of  Pediatric Nephrology 2016:

    Dr. Darío Xavier Jiménez Acosta, Central University of Ecuador, Ecuador
    Dr. Falguni Das, University of Texas Health Science Center, USA
    Dr. Xiaorong Liu, Beijing Children’s Hospital, China
    Dr. K S Nayak, Deccan Institute of Nephrology and Renal Transplantation, India

Conference Series LLC  is privileged to felicitate Pediatric Nephrology 2016 Organizing Committee, Keynote Speakers, Chairs & Co-Chairs and also the Moderator of the conference whose support and efforts made the conference to move in the path of success. Conference Series LLC  thanks every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Pediatric Nephrology 2016

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Pediatric Nephrology 2016.

With the unique and affirmative feedbacks from the conference, We would like to announce the commencement of the 2nd  Annual Meeting on Pediatric Nephrology which will be hosted in June 29-30,2017 Baltimore


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 10-12, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations